Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KHK | P50053 | 11/20 | 1.00 |
| ▸ | MAPK10 | P53779 | 2/20 | 0.47 |
| ▸ | HTR6 | P50406 | 4/20 | 0.46 |
| ▸ | HTR1A | P08908 | 2/20 | 0.46 |
| ▸ | HTR7 | P34969 | 2/20 | 0.46 |
| ▸ | HTR2B | P41595 | 2/20 | 0.46 |
| ▸ | HTR1B | P28222 | 1/20 | 0.46 |
| ▸ | MAPK8 | P45983 | 1/20 | 0.45 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.43 |
| ▸ | SMO | Q99835 | 1/20 | 0.43 |
| ▸ | USP2 | O75604 | 1/20 | 0.42 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20500068 | 1.00 | KHK (1.00) | KHKMAPK10HTR6HTR1AHTR7 | |
| SCHEMBL23734143 | 0.88 | KHK (0.79) | KHKHTR6HTR1AHTR7HTR2B | |
| SCHEMBL24543172 | 0.87 | KHK (0.77) | KHKMAPK10HTR6HTR1AHTR7 | |
| Hydrochloric Acid SCHEMBL29677417 | 0.86 | KHK (0.75) | KHKMAPK10HTR6HTR1AHTR7 | |
| SCHEMBL21791906 | 0.85 | KHK (1.00) | KHKMAPK10HTR6HTR1AHTR7 | |
| SCHEMBL24543229 | 0.82 | KHK (0.71) | KHKMAPK10HTR6HTR1AHTR7 | |
| SCHEMBL24543239 | 0.82 | KHK (0.79) | KHKMAPK10HTR6HTR1AHTR7 | |
| Hydrochloric Acid SCHEMBL29677211 | 0.81 | KHK (0.70) | KHKMAPK10HTR6HTR1AHTR7 | |
| Hydrochloric Acid SCHEMBL29677303 | 0.81 | KHK (0.78) | KHKMAPK10HTR6HTR1AHTR7 | |
| SCHEMBL21791907 | 0.80 | KHK (0.67) | KHKMAPK10HTR6MAPK8NPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250177348-A1 | Methods for Fructokinase Meditation of Alcohol Craving and Alcohol Induced Liver Disease | THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE | 2025-06-05 | — | — | US | disclosed |
| US-12161621-B2 | Methods for fructokinase mediation of alcohol craving and alcohol induced liver disease | THE REGENTS OF THE UNIVERSITY OF COLORADO | 2024-12-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12161621-B2 | Methods for fructokinase mediation of alcohol craving and alcohol induced liver disease | KHK, GCK, FN3K | KHK 1/4885MAPK10 731/4885HTR6 1537/4885 |
| US-20250177348-A1 | Methods for Fructokinase Meditation of Alcohol Craving and Alcohol Induced Liver Disease | KHK, GCK, FN3K | KHK 1/4885MAPK10 1449/4885HTR6 1607/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.